Significant improvements in systolic blood pressure between 4 and 8 mmHg were also observed, along with improvements in patient-reported outcomes, including sleep disturbance and sleep-related daytime impairment [113]
pomaga rwnie chroni narzdy przed powikaniami cukrzycy i wspiera redukcj masy ciaa, co jest szczeglnie wane u pacjentw z otyoci brzuszn lub insulinoopornoci
Zu den Symptomen knnen belkeit, Erbrechen, Schwindel, Durchfall, Bauchschmerzen, Herzvernderungen, Rhythmusstrungen und mehr gehren
Practical strategies can significantly reduce nausea associated with GLP-1 receptor agonist therapy, improving treatment adherence and patient outcomes
Clinical implications of cardiovascular outcome trials in type 2 diabetes
En esta comparacin, quienes tomaban medicamentos GLP-1 tenan casi un 31% menos de probabilidades de cncer de mama